Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer

Overview of attention for article published in Pharmaceutical Research, September 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 10 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 193 Dimensions

Readers on

mendeley: 118 Mendeley
citeulike: 1 CiteULike

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

ANG1005

Cited by user LeadSongDog on 16 Aug 2010

ANG1005 is a promising chemotherapy drug that was developed by a biotechnology company located in Montreal, Canada known as Angiochem Inc.